WHO recommendations on antenatal corticosteroids and tocolytics
Past project
We supported updates to the World Health Organization’s recommendations on the use of certain medications to improve preterm birth outcomes.
The World Health Organization’s recommendations on the use of medications like antenatal corticosteroids and tocolytics needed to be updated in light of new, important evidence on the use of these critical interventions.
We conducted several evidence synthesis activities to support the update of these World Health Organization recommendations, including systematic reviews of quantitative, qualitative and health economic evidence. When published, the recommendations will become the global standard on safe and appropriate use of these interventions.
Timeline
2021–2022.
Partners
Collaborators
- United Nations Development Programme (UNDP)
- United Nations Population Fund (UNFPA)
- UNICEF
- World Bank Special Programme of Research
- Development and Research Training in Human Reproduction (HRP)
- Department of Reproductive Health and Research
Project contacts
Main contacts
Professor Joshua Vogel
Co-Program Director, Women’s, Children’s and Adolescents’ Health; Co-Head, Global Women’s and Newborn’s Health Group; Senior Principal Research Fellow
Project team
Dr Annie McDougall
Senior Research Fellow and Team Leader - Medicines in Pregnancy Research
Professor Caroline Homer AO
Deputy Director – Gender Equity, Diversity & Inclusion; Co-Head, Global Women's and Newborn Health; Co-Head, Immunisation and Health Systems Strengthening
Professor Joshua Vogel
Co-Program Director, Women’s, Children’s and Adolescents’ Health; Co-Head, Global Women’s and Newborn’s Health Group; Senior Principal Research Fellow
Jenny Cao
International Health Project Officer
Kate Mills
Research Officer
